Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Worringer KA"'
Autor:
Rubenstein, John, Sun, Y, Paşca, SP, Portmann, T, Goold, C, Worringer, KA, Guan, W, Chan, KC, Gai, H, Vogt, D, Chen, YJJ
Publikováno v:
Rubenstein, John; Sun, Y; Paşca, SP; Portmann, T; Goold, C; Worringer, KA; et al.(2016). A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6tg8x02v
© Sun et al.Dravet Syndrome is an intractable form of childhood epilepsy associated with deleterious mutations in SCN1A, the gene encoding neuronal sodium channel Nav1.1. Earlier studies using human induced pluripotent stem cells (iPSCs) have produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::f3958d48e976fb029591f6e3fb20e1ba
http://www.escholarship.org/uc/item/6tg8x02v
http://www.escholarship.org/uc/item/6tg8x02v
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene.
Autor:
Kostic M; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Raymond JJ; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Freyre CAC; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Henry B; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Tumkaya T; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States.; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Khlghatyan J; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Dvornik J; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Li J; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Hsiao JS; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Cheon SH; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Chung J; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Sun Y; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Dolmetsch RE; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Worringer KA; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States., Ihry RJ; Neuroscience, Novartis Institutes for BioMedical Research, Cambridge 02139, Massachusetts, United States.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2023 Nov 15; Vol. 14 (22), pp. 3993-4012. Date of Electronic Publication: 2023 Oct 30.
Autor:
Wells MF; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Department of Human Genetics, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA., Nemesh J; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Ghosh S; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Mitchell JM; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Insitro, South San Francisco, CA 94080, USA., Salick MR; Insitro, South San Francisco, CA 94080, USA., Mello CJ; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Meyer D; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Pietilainen O; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Piccioni F; Genetic Perturbation Platform, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA., Guss EJ; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Raghunathan K; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Tegtmeyer M; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA., Hawes D; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA., Neumann A; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA., Worringer KA; Department of Neuroscience, Novartis Institute for BioMedical Research, Cambridge, MA 02139, USA., Ho D; Department of Neuroscience, Novartis Institute for BioMedical Research, Cambridge, MA 02139, USA., Kommineni S; Department of Neuroscience, Novartis Institute for BioMedical Research, Cambridge, MA 02139, USA., Chan K; Department of Neuroscience, Novartis Institute for BioMedical Research, Cambridge, MA 02139, USA., Peterson BK; Department of Neuroscience, Novartis Institute for BioMedical Research, Cambridge, MA 02139, USA., Raymond JJ; Department of Neuroscience, Novartis Institute for BioMedical Research, Cambridge, MA 02139, USA., Gold JT; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Department of Biology, Davidson College, Davidson, NC 28035, USA., Siekmann MT; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Zuccaro E; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Nehme R; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA., Kaykas A; Insitro, South San Francisco, CA 94080, USA., Eggan K; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, and Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA. Electronic address: kevin.eggan@bmrn.com., McCarroll SA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard University, Cambridge, MA 02142, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: smccarro@broadinstitute.org.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2023 Mar 02; Vol. 30 (3), pp. 312-332.e13. Date of Electronic Publication: 2023 Feb 15.
Autor:
Li J, Ho DJ, Henault M, Yang C, Neri M; Chemical and Biological Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland., Ge R, Renner S; Chemical and Biological Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland., Mansur L, Lindeman A, Kelly B, Tumkaya T, Ke X, Soler-Llavina G, Shanker G, Russ C, Hild M, Gubser Keller C; Chemical and Biological Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4056, Switzerland., Jenkins JL, Worringer KA, Sigoillot FD, Ihry RJ
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2022 Jun 17; Vol. 17 (6), pp. 1401-1414. Date of Electronic Publication: 2022 May 04.
Autor:
Ihry RJ; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. Electronic address: robert.ihry@novartis.com., Salick MR; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Insitro, South San Francisco, CA 94080, USA., Ho DJ; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Sondey M; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Abbvie, Cambridge, MA 02139, USA., Kommineni S; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Casma Therapeutics, Cambridge, MA 02139, USA., Paula S; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Raymond J; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Henry B; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Frias E; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Wang Q; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Worringer KA; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Ye C; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Blueprint Medicines, Cambridge, MA 02139, USA., Russ C; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Reece-Hoyes JS; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Altshuler RC; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Randhawa R; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Axcella Health, Cambridge, MA 02139, USA., Yang Z; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; University of Massachusetts Medical School, Worcester, MA 01655, USA., McAllister G; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Sana Biotechnology, Cambridge, MA 02139, USA., Hoffman GR; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Sana Biotechnology, Cambridge, MA 02139, USA., Dolmetsch R; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Kaykas A; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Insitro, South San Francisco, CA 94080, USA. Electronic address: akaykas@gmail.com.
Publikováno v:
Cell reports [Cell Rep] 2019 Apr 09; Vol. 27 (2), pp. 616-630.e6.
Autor:
Ihry RJ; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Worringer KA; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Salick MR; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Frias E; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Ho D; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Theriault K; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Kommineni S; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Chen J; Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Sondey M; Abbvie, Cambridge, MA, USA., Ye C; Blueprint Medicine, Cambridge, MA, USA., Randhawa R; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Kulkarni T; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Yang Z; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., McAllister G; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Russ C; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Reece-Hoyes J; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Forrester W; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Hoffman GR; Department of Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Dolmetsch R; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Kaykas A; Department of Neuroscience, Novartis Institutes for Biomedical Research, Cambridge, MA, USA. ajamete.kaykas@novartis.com.
Publikováno v:
Nature medicine [Nat Med] 2018 Jul; Vol. 24 (7), pp. 939-946. Date of Electronic Publication: 2018 Jun 11.
Autor:
Nehme R; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Zuccaro E; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Ghosh SD; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Li C; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Sherwood JL; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Pietilainen O; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Barrett LE; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Limone F; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Worringer KA; Novartis Institutes for Biomedical Research, Novartis, Cambridge, MA 02139, USA., Kommineni S; Novartis Institutes for Biomedical Research, Novartis, Cambridge, MA 02139, USA., Zang Y; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Cacchiarelli D; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Meissner A; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Adolfsson R; Umea University, Faculty of Medicine, Department of Clinical Sciences, Psychiatry, 901 85 Umea, Sweden., Haggarty S; Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114, USA., Madison J; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Muller M; Novartis Institutes for Biomedical Research, Novartis, 4056 Basel, Switzerland., Arlotta P; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA., Fu Z; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Feng G; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; McGovern Institute for Brain Research in the Department of Brain and Cognitive Sciences at MIT, Cambridge, MA 02139, USA., Eggan K; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA. Electronic address: eggan@mcb.harvard.edu.
Publikováno v:
Cell reports [Cell Rep] 2018 May 22; Vol. 23 (8), pp. 2509-2523.
Autor:
Feuerbach D; Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland. Electronic address: dominik.feuerbach@novartis.com., Schindler P; Biologics Center, Novartis Institutes for Biomedical Research, Basel, Switzerland., Barske C; Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland., Joller S; Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland., Beng-Louka E; Biologics Center, Novartis Institutes for Biomedical Research, Basel, Switzerland., Worringer KA; Neuroscience Research, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Kommineni S; Neuroscience Research, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Kaykas A; Neuroscience Research, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Ho DJ; Neuroscience Research, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Ye C; Neuroscience Research, Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Welzenbach K; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland., Elain G; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland., Klein L; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland., Brzak I; Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland., Mir AK; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland., Farady CJ; Autoimmunity, Transplantation & Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland., Aichholz R; PK Sciences Department, Novartis Institutes for Biomedical Research, Basel, Switzerland., Popp S; Biologics Center, Novartis Institutes for Biomedical Research, Basel, Switzerland., George N; Biologics Center, Novartis Institutes for Biomedical Research, Basel, Switzerland., Neumann U; Neuroscience Research, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Publikováno v:
Neuroscience letters [Neurosci Lett] 2017 Nov 01; Vol. 660, pp. 109-114. Date of Electronic Publication: 2017 Sep 18.